Richard N. Grant Jr. - Apr 9, 2024 Form 4 Insider Report for INTEST CORP (INTT)

Role
President & CEO, Director
Signature
/s/ Richard N. Grant, Jr.
Stock symbol
INTT
Transactions as of
Apr 9, 2024
Transactions value $
-$779,305
Form type
4
Date filed
4/11/2024, 05:34 PM
Previous filing
Mar 12, 2024
Next filing
Aug 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INTT Common Stock Sale -$256K -20K -8.5% $12.80 215K Apr 9, 2024 Direct F1, F2
transaction INTT Common Stock Sale -$265K -22K -10.22% $12.03 193K Apr 10, 2024 Direct F1, F3
transaction INTT Common Stock Sale -$259K -21.5K -11.13% $12.03 172K Apr 11, 2024 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INTT Employee Stock Option (right to buy) 30.5K Apr 9, 2024 Common Stock 30.5K $11.33 Direct F5
holding INTT Employee Stock Option (right to buy) 17K Apr 9, 2024 Common Stock 17K $16.06 Direct F6
holding INTT Employee Stock Option (right to buy) 25.7K Apr 9, 2024 Common Stock 25.7K $9.76 Direct F7
holding INTT Employee Stock Option (right to buy) 112K Apr 9, 2024 Common Stock 112K $10.62 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2023.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.46 to $13.23, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.83 to $12.56, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.91 to $12.20, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 This option vests in four equal annual installments commencing on March 6, 2025.
F6 This option vests in four equal annual installments commencing on March 8, 2024.
F7 This option vests in four equal annual installments commencing on March 9, 2023.
F8 This option vests in four equal annual installments commencing on March 10, 2022.